Anemia and carnitine supplementation in hemodialyzed patients

Kidney International, Supplement

Volumn 55, Issue 69, 1999, Pages

  Kletzmayr, Josef ^a   Mayer, Gert ^b   Legenstein, Elisabeth ^b   Heinz Peer, Gertraud ^b   Leitha, Thomas ^b   Hörl, Walter Hermann ^b   Kovarik, Josef ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Dialysis; End stage renal disease; Erythropoietin; Renal anemia; Vitamin supplements

Indexed keywords

CARNITINE; ERYTHROPOIETIN; IRON SACCHARATE; RECOMBINANT ERYTHROPOIETIN; IRON;

ADULT; AGED; ANEMIA; CARNITINE DEFICIENCY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MIXTURE; ERYTHROCYTE LIFESPAN; FEMALE; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; ERYTHROCYTE COUNT; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ANEMIA; CARNITINE; DOUBLE-BLIND METHOD; ERYTHROCYTE AGING; ERYTHROCYTE COUNT; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0032913808     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ki.4490857     Document Type: Review

References (64)

1. WINEARLS CG: Historical review on the use of recombinant human erythropoietin in chronic renal failure. Nephrol Dial Transplant 10(Suppl 2):3-9, 1995
2. SUNDER-PLASSMANN G, HÖRL WH: Erythropoietin and iron. Clin Nephrol 47:141-157, 1997
3. HAMPERS CL, STREIFF R, NATHAN DG, SNYDER D, MERRILL JP: Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med 276:551-554, 1967
4. RAO DS, SHIH MS, MOHINI R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328:171-175, 1993
5. TOUAM M, MARTINEZ F, LACOUR B, BOURDON R, ZINGRAFF J, DI GIULIO S, DRÜEKE T: Aluminum-induced, reversible microcytic anemia in chronic renal failure: Clinical and experimental studies. Clin Nephrol 19:295-298, 1983
6. MACDOUGALL IC, COLES GA, WILLIAMS JD: Inhibition of a response to erythropoietin in the presence of infection or malignancy. Erythropoiesis 3:29-30, 1992
7. RADTKE HW, REGE AB, LA MERCHE MB, BARTOS D, CAMPBELL RA, FISHER JW: Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure. J Clin Invest 67:1623-1629, 1981
8. SHAW AB: Haemolysis in chronic renal failure. BMJ 2:213-216, 1967
9. DRÜEKE TB: R-HuEPO hyporesponsiveness: Who and why? Nephrol Dial Transplant 10(Suppl 2):62-68, 1995
10. TROVATO GM, GINARDI V, DI MARCO V, DELL'AIRA EE, CORSI M: Long-term L-carnitine treatment of chronic anaemia of patients with endstage renal failure. Curr Ther Res 31:1042-1049, 1982
11. ALBERTAZZI A, CAPELLI P, DI PAOLO B, POLA P, TONDI P, VACCARIO O: Endocrine metabolic effects of L-carnitine in patients on regular dialysis treatment. Proc Ear Dial Transplant Assoc 19:302-307, 1982
12. VACHA GM, GIORCELLI G, SILIPRANDI N, CORSI M: Favorable effects of L-carnitine treatment on hypertriglyceridemia in bemodialysis patients: Decisive role of low levels of high-density lipoprotein-cholesterol. Am J Clin Nutr 38:532-540, 1983
13. BELLINGHIERI G, SAVICA V, MALLAMACE A, Di STEFANO C, CONSOLO F, SPAGNOLI LG, VILLASCHI S, PALMIERI G, CORSI M, MACARI F: Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 38:523-531, 1983
14. BÉRARD E, IORDACHE A: Effect of low dose of L-carnitine on the response to recombinant human erythropoietin in bemodialyzed children: About two cases. Nephron 62:368-369, 1992
15. LABONIA WD: L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am J Kidney Dis 26:757-764, 1995
16. BORAN M, DALCA I, GÖNENC F, CETIN S: Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease. Nephron 73:314-315, 1996
17. KAVADIAS D, FOURTOUNAS C, TSOUCHNIKAS J, BARBOUTIS K: L-carnitine and erythropoietin requirements in hemodialysis patients. (letter) Am J Kidney Dis 28:156, 1996
18. HAECKEI R, KAISER E, OELLERICH M, SILIPRANDI N: Carnitine: Metabolism, function and clinical application. J Clin Chem Clin Biochem 28:291-295, 1990
19. REBOUCHE CJ, CHENARD CA: Metabolic fate of dietary carnitine in human adults: Identification and quantification of urinary and fecal metabolites. J Nutr 121:539-546, 1991
20. ENGEL AG, REBOUCHE CJ: Carnitine metabolism and inborn errors. J Inherit Metab Dis 7(Suppl 1):38-43, 1984
21. BORUM PR, YORK CM, BENNETT SG: Carnitine concentration of red blood cells. Am J Clin Nutr 41:653-656, 1985
22. BORUM PR: Plasma carnitine compartment and red blood cell carnitine compartment of healthy adults. Am J Clin Nutr 46:437-441, 1987
23. REBOUCHE CJ, MACK DL: Sodium gradient-stimulated transport of L-carnitine into renal brush border membrane vesicles: Kinetics, specificity, and regulation by dietary carnitine. Arch Biochem Biophys 235:393-402, 1984
24. SUZUKI M, TOKUYAMA K, KINOSHITA M: Urinary profile of L-carnitine and its derivates in starved normal persons and ACTH injected patients with myopathy. J Nutr Sci Vitaminol 29:303-312, 1983
25. BREMER J: The role of carnitine in intracellular metabolism. J Clin Chem Clin Biochem 28:297-301, 1990
26. SILIPRANDI N, DI LISA F, MENABO R, CIMAN M, SARTORELLI L: Transport and functions of carnitine in muscle. J Clin Chem Clin Biochem 28:303-306, 1990
27. CHALMERS RA, ROE CR, STACEY TE, HOPPEL CL: Urinary excretion of I-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: Evidence for secondary insufficiency of I-carnitine. Pediatr Res 12:1325-1328, 1984
28. COOPER MB, FORTE CA, JONES DA: Carnitine and acetylcarnitine in red blood cells. Biochim Biophys Acta 959:100-105, 1988
29. RAMSAY RR, MANCINELLI G, ARDUINI A: Carnitine palmitoyltransferase in human erythrocyte membrane: Properties and malonyl-CoA sensitivity. Biochem J 275:685-688, 1991
30. ARDUINI A, ROSSI M, MANCINELLI G: Effect of L-carnitine and acetyl L-carnitine on the human erythrocyte membrane stability and deformabuity. Life Sci 47:2395-2400, 1990
31. BUTTERFIELD DA, RANGACHARI A: Acetylcarnitine increases membrane cytoskeletal protein-protein interactions. Life Sci 52:297-303, 1993
32. ARDUINI A, MANCINELLI G, RADATTI GL, DOTTORI S, MOLAJONI F, RAMSAY RR: Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty acid turnover in intact human erythrocytes. J Biol Chem 267:12673-12681, 1992
33. ARDUINI A, TYURIN V, TYURUNA Y, ARRIGONI-MARTELLI E, MOLAJONI F, DOTTORI S, FEDERICI G: Acyl-trafficking in membrane phospholipid fatty acid turnover The transfer of fatty acid from the acyl-L-carnitine pool to membrane phospholipids in intact human erythrocytes. Biochem Biophys Res Commun 187:353-358, 1992
34. ARDUINI A, HOLME S, SWEENEY JD, DOTTORI S, SCIARRONI AF, CALVANI M: Addition of L-carnitine to additive solution-suspended red cell stored at 4°C reduces in vitro hemolysis and improves in vivo viability. Transfusion 37:166-174, 1997
35. BÀHMER T, RYDNING A, SOLBERG HE: Carnitine levels in human serum in health and disease. Clin Chim Acta 57:55-61, 1974
36. WANNER C, HÖRL WH: Carnitine abnormalities in patients with renal insufficiency. Nephron 50:89-102, 1988
37. WANNER C, FÖRSTNER-WANNER S, RÖSSLE C, FÜRST P, SCHOLLMEYER P, HÖRL WH: Carnitine metabolism in patients with chronic renal failure: Effects of L-carnitine supplementation. Kidney Int 32(Suppl 22):S132-S135, 1987
38. MINGARDI G, BIZZI A, CINI M, LICINI R, MECCA G, GARATTINI S: Carnitine balance in hemodialyzed patients. Clin Nephrol 13:269-270, 1980
39. JACKSON JM, LEE HA: L-carnitine and acetyl-L-carnitine status during hemodialysis with acetate in humans: A kinetic analysis. Am J Clin Nutr 64:922-927, 1996
40. LESCHKE M, RUMPF KW, EISENHAUER T, FUCHS C, BECKER K, KÖTHE U, SCHELER F: Quantitative assessment of carnitine loss during hemodialysis and hemofiltration. Kidney Int 24(Suppl 16): S143-S146, 1983
41. WANNER C, WÄCKERLE B, BOECKLE H, SCHOLLMEYER P, HÖRL WH: Plasma and red cell carnitine esters during L-carnitine therapy in hemodialysis patients. Am J Clin Nutr 51:407-410, 1990
42. MOORTHY AV, ROSENBLUM M, RAJARAM R, SHUG AL: A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure. Am J Nephrol 3:205-208, 1983
43. BARTEL LL, HUSSEY JL, SHRAGO E: Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy. Am J Clin Nutr 34:1314-1320, 1981
44. BERTOLI M, BATTISTELLA PA, VERGANI L, NASO A, GASPAROTTO ML, ROMAGNOLI GF, ANGELINI C: Carnitine deficiency induced during hemodialysis and hyperlipidemia: Effect of replacement therapy. Am J Clin Nutr 34:1496-1500, 1981
45. REICHMANN H, VAN LINDENEINER N: Carnitine analysis in normal human red blood cells. plasma and muscle tissue. Eur Neurol 34:40-43, 1994
46. SAVICA V, BELLINGHIERI G, DI STEFANO C, CORVAJA E, CONSOLO F, CORSI M, MACCARI F, SPAGNOLI LG, VILLASCHI S, PALMIERI G: Plasma and muscle carnitine levels in hemodialysis patients with morphological-ultrastructural examination of muscle samples. Nephron 35:232-236, 1983
47. GIOVENALI P, FENOCCHIO D, MONTANARI G, CANCELLOTTI C, D'IDDO S, BUONCRISTLANI U, PELAGGIA M, RIBACCHI R: Selective trophic effect of L-carnitine in type I and II skeletal muscle fibers. Kidney Int 46:1616-1619, 1994
48. PENN D, SCHMIDT-SOMMERFELD E: Carnitine and carnitine esters in plasma and adipose tissue of chronic uremic patients undergoing hemodialysis. Metabolism 32:806-809, 1983
49. KOHSE KP, GRASER TA, FÜRST P, FRANZ HE: Plasma levels of carnitine precursor 6-N-trimethyllysine and maintenance hemodialysis. Kidney Int 32(Suppl 22):S116-S127, 1987
50. SMOGORZEWSKI M, PERNA AF, BORUM P, MASSRY SG: Fatty acid oxidation in the myocardium: Effects of parathyroid hormone and CRF. Kidney Int 34:797-803, 1988
51. DE LOS REYES B, NAVARRO JA, PÉREZ-GARCIA R, LIRAS A, CAMPOS Y, BORNSTEIN B, ARENAS J: Effects of L-carnitine on erythrocyte acyl-CoA, free CoA. and glycerophospholipid acyltransferase in uremia. Am J Clin Nutr 67:386-390, 1988
52. UEMURA O, GOTO Y, IWASA M, ANDO T, SATO K, TOMINAGA Y, UCHIDA K, ICHIKI T, SUGIYAMA N: Secondary carnitine palmitoyltransferase deficiency in chronic renal failure and secondary hyperparathyroidism. Tohoku J Exp Med 178:307-314, 1996
53. DE LOS REYES B, PÉREZ-GARCIA R, LIRAS A, VALDARRABANO F, ARENAS J: L-carnitine normalizes the reduced carnitine palmitoyl transferase activity in red cells from hemodialysis patients. (letter) Nephrol Dial Transplant 12:1300-1301, 1997
54. FARRELL S, VOGEL J, BIEBER LL: Entry of acetyl-L-carnitine into biosynthetic pathways. Biochim Biophys Acta 876:175-177, 1986
55. MATSUMURA M, HATAKEYAMA S, KONI I, MABUCHI H, MURAMOTO H: Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients. Nephron 72:574-578, 1996
56. DONATELLI A, TERRIZZI C, ZUMMO G, Russo V, BUCALO ML, SCARPINATO A: Effects of L-carnitine on chronic anemia and erythrocyte adenosine triphosphate concentration in hemodialyzed patients. Curr Ther Res 41:620-624, 1987
57. LINDE T, SANDHAGEN B, WIKSTRÖM B, DANIELSON BG: The required dose of erythropoietin during renal anemia treatment is related to the degree of impairment in erythrocyte deformability. Nephrol Dial Transplant 12:2375-2379, 1997
58. BÉRARD E, BARILLON D, IORDACHE A, BAYLE J, CASSUTO-VIGUIER E: Low dose of L-carnitine impairs membrane fragility of erythrocytes in hemodialysis patients. (letter) Nephron 68:145, 1994
59. CEDERBLAD G, LINDSTEDT S: A method for the determination of carnitine in the picomole range. Clin Chim Acta 37:235-240, 1972
60. LOHNINGER A, KAISER E, LEGENSTEIN E, STANIEK H: Carnitine, metabolism and function, in Carnitine: Its Role in Heart and Lung Disorders, edited by KAISER E, LOHNINGER A, Basel, Karger, 1987. pp 1-25
61. ISCH PANEL ON DIAGNOSTIC APPLICATIONS OF RADIOISOTOPES IN HAEMATOLOGY: Recommended methods for radioisotope red-cell survival studies. Br J Haematol 21:241-250, 1971
62. ALHOMIDA AS: Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients. Arch Med Res 28:101-107, 1997
63. DEUFEL T: Determination of L-carnitine in biological fluids and tissues. J Clin Chem Clin Biochem 28:307-311, 1990
64. KOOISTRA MP, STRUYVENBERG A, VAN Es A: The response to recombinant human erythropoietin in patients with the anemia of endstage renal disease is correlated with serum carnitine levels. Nephron 57:127-128, 1991